Publicly Traded Life Sciences Companies and Artificial Intelligence: Disclosing Risk Factors
JD Supra Although the rise ofartificial intelligence(AI) has created many opportunities and breakthroughs for life sciences companies in preclinical and …
Read the original at JDSupra ↗
- Topics
- Healthcare
- Tags
- AI Use Case
- Tracked via
- Google Alert “AI Risks”